🔗 Share this article

An underground market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, according to new investigations.

Experimental Drug Acquiring Popularity Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles directly for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Separately, a robust trade exists on Telegram, where communities with thousands of participants share “before and after” images, injection guides and assertions of rapid British shipping. Sellers promote the substance there before directing customers to WhatsApp for transactions.

Learning About The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could assist individuals reduce up to 25% of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to individuals administering products of uncertain source.

Several professionals said the popularity for retatrutide could be linked to the rising cost of approved slimming treatments such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the UK, as it is an unlicensed medication that must not be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Service Reaction and Content Removal

According to TikTok, the platform has taken down problematic content and prohibited related hashtags and query recommendations. The organization said it was dedicated to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Digital Trading Operations

Investigations also found communities with up to 9,000 participants selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” instantly displays groups with numerous of users, populated with photos of slimming results, positive testimonials and detailed instructions for preparing or administering at home.

Within moments of entering one community, a vendor posted WhatsApp details, where most purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When asked whether the substance was genuine, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. Not one inquired about weight, medical conditions or past usage.

Item Information and Costs

Inside these groups, posts display dark colored packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When questioned how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively moderated dangerous content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they claim,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

A medical professional of an online medical service linked the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she explained.

Her staff has previously seen patients injured by self-injection from unconfirmed sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly investigational product not yet approved … may subject users to possibly significant health risks”.